The glycosylation of the complement regulatory protein, human erythrocyte CD59
Rudd PM, Morgan BP, Wormald MR, Harvey DJ, van den Berg CW, Davis SJ, Ferguson MA, Dwek RA. (1998), Adv Exp Med Biol. 435, 153-62
CD2 and the nature of protein interactions mediating cell-cell recognition
Davis SJ, Ikemizu S, Wild MK, van der Merwe PA. (1998), Immunol Rev. 163, 217-36
The role of charged residues mediating low affinity protein-protein recognition at the cell surface by CD2
Davis SJ, Davies EA, Tucknott MG, Jones EY, van der Merwe PA. (1998), Proc Natl Acad Sci U S A. 95, 5490-4
Roles for glycosylation in the anti-inflammatory molecule CD59
Rudd PM, Morgan BP, Wormald MR, Harvey DJ, van den Berg CW, Davis SJ, Ferguson MA, Dwek RA. (1997), Biochem Soc Trans. 25, 1177-84
Characterisation of the low affinity interaction between rat cell adhesion molecules CD2 and CD48 by analytical ultracentrifugation
Silkowski H, Davis SJ, Barclay AN, Rowe AJ, Harding SE, Byron O. (1997), Eur Biophys J. 25, 455-62
CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics
van der Merwe PA, Bodian DL, Daenke S, Linsley P, Davis SJ. (1997), J Exp Med. 185, 393-403.
Mutational analysis of the active site and antibody epitopes of the complement-inhibitory glycoprotein, CD59
Bodian DL, Davis SJ, Morgan BP, Rushmere NK. (1997), J Exp Med. 185, 507-16
The glycosylation of the complement regulatory protein, human erythrocyte CD59
Rudd PM, Morgan BP, Wormald MR, Harvey DJ, van den Berg CW, Davis SJ, Ferguson MA, Dwek RA. (1997), J Biol Chem. 272, 7229-44
NMR analysis of interacting soluble forms of the cell-cell recognition molecules CD2 and CD48
McAlister MS, Mott HR, van der Merwe PA, Campbell ID, Davis SJ, Driscoll PC. (1996), Biochemistry. 35, 5982-91
CD2: an exception to the immunoglobulin superfamily concept?
Davis SJ, van der Merwe PA. (1996), Science. 273, 1241-2